ISB News

Dr. Lee Hood and 100K Wellness Project in Yahoo! News

Photo of Dr. Lee Hood

(ABOVE: Dr. Lee Hood, President of Institute for Systems Biology, spoke about phase one of the 100K Wellness Project while attending the AAAS conference in Chicago on Feb. 14, 2014. Photo by Kerry Sheridan/Agence France-Presse)

Agence France-Presse reporter Kerry Sheridan interviewed Dr. Lee Hood on Feb. 14, 2014, about the first phase of the 100K Wellness Project. An excerpt from the article:

"The Hundred Person Wellness Project, which begins next month, will require round-the-clock monitoring of its subjects, who are presumed healthy at the time of enrollment.

Scientists will start by sequencing the entire genome of each participant. Then, for the next 25 years, they will take regular measurements of sleep patterns, heart rate, gut bacteria, proteins that track organ health, blood samples, immune cell activity and more."

To read the full article, please visit this link.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.